Relationship between acquired deficiency of vitamin K-dependent clotting factors and hemorrhage

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 30, Issue 3, 2010, Pages 312-317

  Yang, Rui ^a,b   Zhang, Xiaoping ^a,b   Wei, Wenning ^a,b   Hong, Mei ^a,b   Yang, Yan ^a,b   Hu, Yu ^a,b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Hubei Key Laboratory of Biological Targeted Therapy   (China)

Author keywords

Coagulation factor; Deficiency; Hemorrhage; Vitamin K

Indexed keywords

PLASMA PROTEIN; VITAMIN K GROUP;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; BLOOD; BLOOD CLOTTING DISORDER; CASE CONTROL STUDY; CHILD; FEMALE; HUMAN; MALE; METABOLISM; RETROSPECTIVE STUDY;

ADOLESCENT; ADULT; BLOOD COAGULATION DISORDERS; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHILD; FEMALE; HEMORRHAGE; HUMANS; MALE; RETROSPECTIVE STUDIES; VITAMIN K; YOUNG ADULT;

EID: 77956375723     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-010-0348-1     Document Type: Article

References (32)

1. Cranenburg EC, Schurgers LJ, Vermeer C. Vitamin K: the coagulation vitamin that became omnipotent. Thromb Haemost, 2007, 98(1):120-125
2. Harrington DJ, Western H, Seton-Jones C, et al. A study of the prevalence of vitamin K deficiency in patients with cancer referred to a hospital palliative care team and its association with abnormal haemostasis. J Clin Pathol, 2008, 61(4):537-540
3. Shearer MJ. Vitamin K metabolism and nutriture. Blood Rev, 1992, 6(2):92-104
4. Oldenburg J, Watzka M, Rost S, et al. VKORC1: Molecular target of coumarins. J Thromb Haemost, 2007, 5 (Suppl 1):1-6
5. Wallin R, Wajih N, Hutson SM. VKORC1: a warfarin-sensitive enzyme in vitamin K metabolism and biosynthesis of vitamin K-dependent blood coagulation factors. Vitam Horm, 2008, 78:227-246
6. Blanchard RA, Furie BC, Jorgensen M, et al. Acquired vitamin K-dependent carboxylation deficiency in liver disease. N Engl J Med, 1981, 305(5):242-248
7. Furie B, Furie BC. Mechanisms of Thrombus Formation. N Engl J Med, 2008, 359(9):938-949
8. Dam H, Schonheyder F. A deficiency disease in chicks resembling scurvy. Biochem J, 1934, 28(4):1355-1359
9. Furie B, Furie BC. Molecular and cellular biology of blood coagulation. N Engl J Med, 1992, 326(12):800-806
10. Rapaport SI. Coagulation problems in liver disease. Blood Coagul Fibrinolysis, 2000, 11 (Suppl 1): S69-74
11. Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol, 2002, 37(2):280-287
12. Amiral J, Fareed J. Thromboembolic diseases: biochemical mechanisms and new possibilities of biological diagnosis. Semin Thromb Hemost, 1996, 22 (Suppl 1):41-48
13. Penning-van Beest FJ, Gómez García EB, van der Meer FJ, et al. Levels of vitamin K-dependent procoagulant and anticoagulant proteins in over-anticoagulated patients. Blood Coagul Fibrinolysis, 2002, 13(8):733-739
14. Senzolo M, Burra P, Cholongitas E, et al. New insights into the coagulopathy of liver disease and liver transplantation. World J Gastroenterol, 2006, 12(48):7725-7736
15. Wiedermann CJ, Stockner I. Warfarin-induced bleeding complications- clinical presentation and therapeutic options. Thromb Res, 2008, 122 (Suppl 2): S13-18
16. van Hasselt PM, de Koning TJ, Kvist N, et al. Netherlands Study Group for Biliary Atresia Registry. Prevention of vitamin K deficiency bleeding in breastfed infants: lessons from the Dutch and Danish biliary atresia registries. Pediatrics, 2008, 121(4):e857-863
17. Papadopoulos V, Filippou D, Manolis E, et al. Haemosta-sis impairment in patients with obstructive jaundice. J Gastrointestin Liver Dis, 2007, 16(2):177-186
18. Pereira SP, Rowbotham D, Fitt S, et al. Pharmacokinetics and efficacy of oral versus intravenous mixed-micellar phylloquinone (vitamin K1) in severe acute liver disease. J Hepatol, 2005, 42(3):365-370
19. Kerr R, Newsome P, Germain L, et al. Effects of acute liver injury on blood coagulation. J Thromb Haemost, 2003, 1(4):754-759
20. Wong RS, Cheng G, Chan NP, et al. Use of cefoperazone still needs a caution for bleeding from induced vitamin K deficiency. Am J Hematol, 2006, 81(1):76
21. Rashid M, Durie P, Andrew M, et al. Prevalence of vitamin K deficiency in cystic fibrosis. Am J Clin Nutr, 1999, 70(3):378-382
22. Chen CS, Cumbler EU, Triebling AT. Coagulopathy due to celiac disease presenting as intramuscular hemorrhage. J Gen Intern Med, 2007, 22(11):1608-1612
23. Sundaram A, Koutkia P, Apovian CM. Nutritional management of short bowel syndrome in adults. J Clin Gas-troenterol, 2002, 34(3):207-220
24. Prentice CR. Acquired coagulation disorders. Clin Haematol, 1985, 14(2):413-442
25. Kuzu MA, Kale IT, Cöl C, et al. Obstructive jaundice promotes bacterial translocation in humans. Hepatogas-troenterology, 1999, 46(28):2159-2164
26. Bruno GR, Howland MA, McMeeking A, et al. Long-acting anticoagulant overdose: brodifacoum kinetics and optimal vitamin K dosing. Ann Emerg Med, 2000, 36(3):262-267
27. Spahr JE, Maul JS, Rodgers GM. Superwarfarin poisoning: a report of two cases and review of the literature. Am J Hematol, 2007, 82(7):656-660
28. Girolami A, Scandellari R, Scapin M, et al. Congenital bleeding disorders of the vitamin K-dependent clotting factors. Vitam Horm, 2008, 78:281-374
29. Ben-Tal O, Zwang E, Eichel R, et al. Vitamin K-dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawing. Transfusion, 2003, 43(7):873-877
30. Leissinger CA, Blatt PM, Hoots WK, et al. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature. Am J Hematol, 2008, 83(2):137-143
31. Hoffman CJ, Lawson WE, Miller RH, et al. Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults. Arterioscler Thromb, 1994, 14(11):1737-1740
32. Kamali F, Edwards C, Wood P, et al. Temporal variations in plasma vitamin K and lipid concentrations and clotting factor activity in humans. Am J Hematol, 2001, 68(3):159-163